A fundamental element of acute lung injury (ALI) is the inflammatory response, which can affect the entire respiratory system, including the respiratory tract and alveoli.
| INTRODUCTION
Acute lung injury (ALI) is a severe clinical condition that may lead to acute respiratory failure and death and is characterized by respiratory distress, refractory hypoxemia, and noncardiogenic pulmonary edema (Wheeler & Bernard, 2007) . Pathologically, ALI is regarded as an acute severe inflammatory process characterized by a widespread loss of epithelial and endothelial integrity (Ware & Matthay, 2000) . Airway epithelia, a vital structure that separates the internal milieu of the host from the outside world, are not only a mechanical barrier to external stimuli and microbes but also actively involved in innate and acquired immune responses and airway inflammation (Rubenfeld et al., 2005) .
Severe sepsis is the primary cause of ALI. In addition, lipopolysaccharide (LPS), which is derived from the outer membrane of gram-negative bacteria, can induce the features of acute inflammation in the pulmonary and tracheal epithelium (Hu et al., 2016) , including the † Yuan Liang, Chongxi Fan, and Xiaolong Yan contributed equally to this work. upregulation of interleukins (such as and the regulation of downstream molecular pathways. Although significant progress has been made toward understanding the pathophysiology of ALI, only supportive treatment has reduced ALI-related mortality (Matthay, Ware, & Zimmerman, 2012) . Therefore, new drugs and new therapeutic strategies against excessive inflammation are an urgent priority for ALI prevention.
Berberine, the principal isoquinoline alkaloid constituent of many popular medicinal plants (e.g., the Berberis, Coptis, and Hydrastis, among others; Figure 1a ), has historically been used in traditional Chinese medicine due to its various biological activities, including antidiarrheal, anticancer, antidiabetic, antihyperlipidemic, and cardioprotective effects (Menees, Saad, & Chey, 2012; Pirillo & Catapano, 2015 ; H. L. Tan et al., 2016; W. Tan, Li, Chen, & Wang, 2011) . Notably, berberine has attracted considerable attention because of its anti-inflammatory activity in vitro and in vivo (Caliceti, Franco, Spinozzi, Roda, & Cicero, 2016; Seo, Fischer, & Efferth, 2018; Xie & Du, 2011) . However, considering the extensive pharmacological effects of berberine and the complex molecular mechanisms of ALI, the protective effect of berberine against LPS-induced ALI requires further study.
The endoplasmic reticulum (ER) is a single lipid bilayer separated from the surrounding cytosol that constitutes an extensive tubularreticular network (Oakes & Papa, 2015) . The ER is a crucial eukaryotic organelle responsible for the synthesis and folding of secreted and transmembrane proteins (Todd, Lee, & Glimcher, 2008) . During these processes, the overaccumulation of unfolded and misfolded proteins in the ER activates an evolutionary response called the unfolded protein response and disrupts energy/nutrient homeostasis, also known as ER stress (Hetz, 2012) . To maintain and improve ER function during ER stress, three membrane protein sensors are activated, including inositol-requiring 1α, protein kinase R-like ER kinase (PERK), and activating transcription factor 6 (Hetz, 2012) . These proteins have a luminal sensor/transducer domain that is retained in an inactive state through association with glucose-regulated protein 78 (GRP78; Pincus et al., 2010) . Recent studies have demonstrated that ER stress, particularly the PERK pathway, is involved in lung injury with different etiologies in vitro, including LPS-induced alveolar and smoke-induced airway epithelial damage (Hrincius et al., 2015 ; S. R. Kim et al., 2015) . Moreover, although berberine negatively regulates ER stress in multisystem inflammatory diseases, the protective effect of berberine in LPS-induced ALI remains unclear (T. Kim, Hinton, Johng, Wang, & Choi, 2013; Z. S. Wang, Lu, Xu, & Dong, 2010; Zhao et al., 2016 ).
The nuclear factor-erythroid 2-related factor 2 (Nrf2) transcription factor is a unique Cap'n'Collar-basic leucine zipper transcription factor that is currently considered a master regulator of cellular homeostasis, which is achieved by the binding of Nrf2 to its most prominent inhibitor, Kelch-like ECH-associated protein 1 (KEAP1; Ma, 2013) . In lung tissue, Nrf2 is predominantly found in the epithelium, which has been implicated in several pulmonary diseases, such as acute respiratory distress syndrome (ARDS), pulmonary fibrosis, asthma, and chronic obstructive pulmonary disease (Boutten, Goven, Artaud-Macari, Boczkowski, & Bonay, 2011; Boutten, Goven, Boczkowski, & Bonay, 2010; Cho, Reddy, & Kleeberger, 2006) .
Recently, berberine was reported to enhance the effects of antioxidants through Nrf2 activation and reduce the bleomycin-induced inflammatory response, histological alterations, and collagen deposition (Chitra, Saiprasad, Manikandan, & Sudhandiran, 2013) . Importantly, Cullinan et al. demonstrated that PERK may be involved in mediating Nrf2 phosphorylation and translocation in myocardial ischemia-reperfusion injury (Cullinan et al., 2003; Cullinan & Diehl, 2004) .
Collectively, given the contribution of ER stress and Nrf2 to infectious and inflammatory processes, the possible interaction of these factors in LPS-induced ALI is emerging as a pathogenic component of infectious pulmonary disorders. Moreover, because berberine can regulate ER stress or Nrf2 in some inflammation-related diseases, in FIGURE 1 Effect of berberine on the morphology, viability, and lactate dehydrogenase (LDH) content of the 16HBE bronchial epithelial cell line. (a) Chemical structure of berberine. (b) Effect of berberine pretreatment (0.25, 2.5, 25, and 250 μM) for 24 hr on the morphology and structure of 16HBE cells as shown by bright field microscopy (200× magnification), whereas formazan dye generation in 16HBE cells was measured at 450 nm with a microplate reader (c) (n = 6). (d) Effect of berberine pretreatment (0.25, 2.5, 25, and 250 μM) for 24 hr on LDH release in 16HBE cells (n = 6). Cells treated with 1% Triton X-100 solution were used as a positive control. Values are expressed as the mean ± SEM. Statistical significance is indicated as * p < 0.001 versus the control group (each test was repeated three times) [Colour figure can be viewed at wileyonlinelibrary.com] the present investigation, we first elucidated the role of ER stress or Nrf2 in the protective effect of berberine against LPS-induced ALI in vitro and in vivo. Then, we focused on the link between ER stress and Nrf2 using specific small RNA interference sequences and agonists in the human airway epithelial cell line (16HBE). Consequently, these findings indicate a new protective effect of berberine on LPSinduced ALI and identify inflammation-related mechanisms that are associated with PERK-Nrf2 axis regulation.
| MATERIALS AND METHODS

| Reagents and chemicals
Berberine chloride (C 20 H 18 ClNO 4 ), LPS (lipopolysaccharide from Escherichia coli 055:B5), thapsigargin (Tg), sulforaphane (SF), 4′,6-diamidino-2-phenylindole (DAPI), and sodium pentobarbital were purchased from Sigma-Aldrich (St. Louis, MO, USA). Newborn calf serum (NBS), 0.25% trypsin-EDTA, RPMI-1640 medium, and phosphate buffered saline (PBS) were obtained from Gibco Laboratories (Life Technologies, Inc., Burlington, ON, Canada). A CCK-8 assay kit was purchased from Dojindo Laboratories (Tokyo, Japan). The small interference RNAs (siRNAs) against human PERK and nontarget mRNA were obtained from Qiagen (Hilden, Germany). Nrf2 siRNA was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The primary antibodies used in this study were phosphor-Nrf2 (p-Nrf2), Nrf2, heme oxygenase 1 (HO-1), and GRP78 from Abcam (Cambridge, MA, USA); phospho-PERK (p-PERK) from Santa Cruz Biotechnology (Dallas, Texas, USA); PERK, phospho-eIF2α (p-eIF2α), α-subunit of eukaryotic translation initiation factor 2 (eIF2α), and C/EBP homologous protein (CHOP) from Cell Signaling Technology (Beverly, MA, USA); and Lamin B1 and β-actin from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Cy3-AffiniPure Goat Anti-Rabbit and Alexa Fluor® 488 AffiniPure Goat Anti-Mouse secondary antibodies were obtained from Yisheng Biotechnology Co., Ltd. (Shanghai, China). The horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit secondary antibodies were obtained from Zhongshan Biotechnology Co., Ltd.
(Beijing, China). BCA protein assay kits were supplied by Pierce Biotechnology (Rockford, IL, USA). Enzyme-linked immunosorbent assay (ELISA) kits for human inflammatory proteins IL-6 and IL-8 were purchased from R&D Systems (Minneapolis, MN, USA), and the ELISA kits for mouse IL-6 and keratinocyte-derived cytokine (KC; mouse IL-8 equivalent) were purchased from Neobioscience (Shenzhen, Guangdong, China). A TransAM™ Nrf2 kit was purchased from Active Motif (Carlsbad, CA, USA). A cytotoxicity detection kit (lactate dehydrogenase, LDH) and protease and phosphatase inhibitors were purchased from Roche Molecular Diagnostics (Pleasanton, CA, USA).
Lipofectamine RNAiMax transfection reagent and TRIzol reagent were purchased from Invitrogen (Carlsbad, CA, USA). PrimeScript™ RT Master Mix and TB Green™ Premix Ex Taq™ II were purchased from Takara Bio Inc. (Kusatsu, Shiga, Japan). Wright-Giemsa and Evans blue dye were purchased from Solarbio Life Sciences (Beijing, China). MPO test kits were obtained from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). A reactive oxygen species (ROS) assay kit, radio immunoprecipitation assay (RIPA) buffer, and a nuclear and cytoplasmic protein extraction kit were purchased from Beyotime Institute of Biotechnology (Haimen, China).
| Cell culture
A human bronchial epithelial cell line (16HBE) was purchased from American Type Culture Collection (Manassas, VA, USA) and cultured in RPMI-1640 medium supplemented with 10% NBS, 100 units/ml penicillin, and 100-mg/ml streptomycin in a humidified atmosphere containing 5% CO 2 and 95% O 2 at 37°C. The medium was changed every 24 hr. Cells that had undergone fewer than 20 passages were used throughout the experiment.
| Cell stimulations
First, a range of berberine concentrations (0.25, 2.5, 25, or 250 μM) was used for 24 hr to identify an optimal noncytotoxic dose for further experiments. Next, 16HBE cells were treated with different doses of berberine for 4 hr before LPS stimulation (100 ng/ml) for an additional 24 hr. Treatments of Tg (1 μM) or SF (4 μM) for 4 hr were also applied to explore the roles of ER stress or Nrf2 in the protective effect of berberine against LPS-induced ALI.
| CCK-8 assay
To determine the number of viable cells, formazan dye generation was measured using CCK-8 kits. After different treatments, 16HBE cells were treated with CCK-8 solution in 96-well plates, and then, the plates were incubated in a humidified atmosphere containing 5% CO 2 and 95% O 2 at 37°C for 2 hr. The absorbance at 450 nm was measured using a microplate reader (SpectraMax 190, Molecular Device, Sunnyvale, CA, USA).
| LDH assay for cytotoxicity
The cytotoxicity of berberine was measured by quantification of LDH, an indicator of cell membrane damage, in cell culture supernatants with a commercial assay kit according to a previous study (Hardyman et al., 2013) . Total cellular LDH release was determined in 16HBE cell lysates collected following treatment with 1% Triton X-100 solution as the positive control. Correspondingly, untreated cells were used as a negative control.
| Nrf2-antioxidant response element binding assay
An ELISA-based DNA-binding assay was used to investigate the effects of berberine on the DNA-binding activity of Nrf2 in an LPS-induced acute airway inflammatory cell model according to the published report and operating instructions (Guan et al., 2013) . Briefly, 16HBE cells were scraped into ice-cold hypotonic buffer (20-mM HEPES, 5-mM NaF, 10-μM Na 2 MoO 4 , and 0.1-mM EDTA, pH 7.5, dissolved in 50 ml of distilled water, stored at 4°C) and incubated for 20 min. After centrifugation for 30 s at 4°C, the supernatant (principally, the cytoplasmic fraction) was removed, and the nuclear pellet was resuspended in 50 μl of complete lysis buffer and rocked gently on ice for 30 min. The suspension was recentrifuged for 10 min at 14,000 g and 4°C, and the supernatant (principally, the nuclear extract) was stored at −80°C, avoiding freeze/thaw cycles. The ELISA kit included a 96-well plate to which an oligonucleotide containing the antioxidant response element (ARE) consensus binding site (5′-GTC ACA GTG ACT CAG CAG AAT CTG-3′) had been immobilized. A total of 40 μl of complete binding buffer was added to each well followed by 20 μg of nuclear extract. The plate was covered and rocked (100 rpm) for 1 hr at room temperature. Subsequently, Nrf2 antibody (1:1,000) and then horseradish peroxidase-conjugated secondary antibody (1:1,000) were each added and incubated for 1 hr at room temperature. The absorbance was read on a microplate reader (SpectraMax 190, Molecular Device, Sunnyvale, CA, USA) at 450 nm (L. Wang et al., 2017) .
2.7 | RNA extraction and real-time quantitative polymerase chain reaction assay Total RNA isolation and real-time polymerase chain reaction (PCR) were conducted as previously described (Li et al., 2016; Yao et al., 2017) . Briefly, 16HBE cells were treated with different doses of berberine (2.5, 5, or 10 μM) for 4 hr followed by 100-ng/ml LPS for 24 hr. Total RNA was isolated from cells with TRIzol reagent. After isolation, RNA quality was assessed on a NanoDrop2000 spectropho- to ensure amplification of a single product. The mRNA levels were calculated using the 2 −ΔΔCt method (relative fold change). GAPDH was amplified as an internal control.
| Measurement of intracellular ROS
The ROS level in vitro was analyzed by 2′,7′-dichlorofluorescein diacetate (DCFH-DA) staining. The cells were treated with berberine (5 and 10 μM) for 4 hr followed by LPS stimulation (100 ng/ml) for 24 hr. The cells were then washed with PBS three times. DCFH-DA diluted with serum-free RPMI-1640 culture medium to a final concentration of 10 μM was used to cover the cells for 20 min at 37°C. After the cells were washed with serum-free RPMI-1640 three times, DCF fluorescence was recorded with an FV1000 Olympus confocal microscope (Olympus, Tokyo, Japan) at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. Then, the fluorescence intensity was calculated using Image Pro-Plus software (Media Cybernetics, Rockville, MD, USA).
| PERK and Nrf2 siRNAs
The 16HBE cells were seeded onto six-well plates at 0.5 × 10 6 cells per well and grown to 80% confluence. The cells were then transfected with specific siRNAs against PERK and Nrf2 for 48 hr using Lipofectamine RNAiMax transfection reagent according to the manufacturer's protocol. Small interference RNA efficiency was analyzed by western blot analysis as described in previous studies. For berberine treatment, at 48 hr after siRNA transfection, LPS-induced 16HBE cells were treated with 5-μM berberine for an additional 4 hr.
| Animals
All animal experimental procedures in the present study were con- (12-hr light-dark cycle, 50 ± 10% relative humidity) at 23 ± 2°C and were allowed ad libitum access to standard chow and sterile water.
Body weight was monitored throughout the experiment.
| Lung injury models and histological analysis of lung tissues
The ALI models were established with LPS treatment as described in previous studies (Gong et al., 2014; Lv et al., 2017; Xu et al., 2016; Zou et al., 2017) . Briefly, all animals were anesthetized intraperitoneally with 80 mg/kg of 2% sodium pentobarbital. Then, mice were randomly divided into five groups: control (saline +0.5% DMSO), berberine only (10 mg/kg, dissolved in 0.5% DMSO), LPS only (2.5 mg/kg, dissolved in saline), berberine (10 mg/kg) + LPS, and dexamethasone (DXM; as a positive drug, 5 mg/kg dissolved in saline) + LPS.
LPS was injected intratracheally in 40-50 μl by endotracheal intubation for four or five times with 1-to 2-min intervals. Berberine and DXM were also administered intraperitoneally once 24 hr before and again at 2 hr before LPS treatment Lv et al., 2017; Mo et al., 2014) . After LPS challenge for an additional 24 hr, the animals were euthanized by an overdose of sodium pentobarbital. Subsequently, lung tissue samples and bronchoalveolar lavage fluid (BALF)
were collected for further experiments.
The lungs of mice were flushed with 4% paraformaldehyde and fixed for 48 hr, dehydrated in a graded ethanol series, embedded in paraffin wax, and cut into 5-μm-thick sections. These sections were then stained with hematoxylin and eosin and examined under a light microscope with a 600D camera (Canon Company, Japan). Lung injury was evaluated and scored by an investigator blinded to experimental grouping against a recently released criterion, and lung damage was assessed on a 2-point scale, ranging from 0 to 1 (Matute-Bello et al., 2011; Xu et al., 2016) .
| BALF collection and analysis
The mice were euthanized by terminal anesthesia for BALF collection at 24 hr after the injection of LPS. The chest cavity was exposed to allow for expansion, after which the trachea was carefully intubated.
Lavage was performed by introducing 1 ml of precooled PBS via a tracheal cannula, and the fluid was slowly withdrawn. This procedure was repeated three times for each mouse. The recovery rate of the lavage solution was approximately 90 ± 5%. Cells in BALF were collected after centrifugation at 400 g for 10 min at 4°C and counted on a hemocytometer under a light microscope with a 600D camera (Canon Company, Japan). The slides were prepared using methanol fixation and stained by the Wright-Giemsa method. In addition, the protein concentrations in the supernatant of BALF were measured with a BCA protein assay kit.
| Evaluation of pulmonary edema and bronchoalveolar epithelial permeability
The amount of extravascular lung fluid, a sensitive indicator of pulmonary edema, was calculated. The right lung was isolated from the thoracic cavity, and the wet lung tissues were weighed. After desiccation in an oven at 80°C for 48 hr, the dry weight was recorded. The wet/ dry (W/D) weight ratio was then calculated to assess tissue edema.
Alveolar leakage was evaluated by measuring extravascular Evans blue dye in the lung. After LPS treatment, the mice were injected with Evans blue solution (20 mg/kg) intravenously at 1 hr before euthanasia. The lungs were then perfused with PBS to remove blood, blotted dry, weighed, and snap frozen in liquid nitrogen. The right lung was homogenized in PBS (1-ml/100 mg tissue) on ice and incubated with two volumes of formamide at 60°C for 18 hr before centrifugation.
The optical density of the supernatant was measured at 620 nm and corrected at 740 nm by a microplate reader. Standard curves for the Evans blue dye were generated using a solution of Evans blue dye (dissolved in PBS) at concentrations of 0.125 to 31.25 g/ml (Moitra, Sammani, & Garcia, 2007; Zou et al., 2017) .
| Measurement of MPO activity
At the end of the experiment, the mice were euthanized by an over- 
| Enzyme-linked immunosorbent assay
The 16HBE cells were cultured in six-well plates with different treatments. Next, the cell culture medium samples were collected and centrifuged at 400 g for 10 min, and the supernatant fractions were stored at −80°C for analysis of the inflammatory proteins IL-6 and IL-8. Meanwhile, the BALF was centrifuged for measurement of the IL-6 and KC content according to the kit manufacturer's instructions.
| Double immunofluorescence analysis
The 16HBE 
| Western blot analysis
To isolate the total cellular protein, 16HBE cells and lung tissues were lysed in cold RIPA buffer containing protease and phosphatase inhibitors on ice for 15 min followed by centrifugation for 20 min at 12,000 g at 4°C. The nuclear and cytoplasmic fractions were isolated using a cytoplasm extraction kit according to the manufacturer's instructions. The protein concentrations in the supernatant were measured using a BCA protein assay kit. Next, 30 μg of protein was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis with the Mini-PROTEAN® Tetra Vertical Electrophoresis Cell (BioRad, West Berkeley, CA, USA) and transferred to a nitrocellulose membrane (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA). The membranes were blocked with 5% nonfat dry milk (dissolved in 1× TBS-0.05% Tween 20) for 2 hr followed by overnight incubation at 4°C with specific primary antibodies as follows: p-Nrf2 (1:5,000; only for human cells), Nrf2 (1:1,000), HO-1 (1:250), p-PERK (1:1,000; only for human cells), PERK (1:1,000; only for human cells), p-eIF2α
(1:1,000), eIF2α (1:1,000), GRP78 (1:1,000), CHOP (1:1,000), Lamin B1 (1:500), and β-actin (1:500). The following day, a corresponding secondary antibody (1:5,000) was applied for 1.5 hr at room temperature. Ultimately, the signals were visualized using an electrochemiluminescence system (Bio-Rad, West Berkeley, CA, USA), and the relative intensity of the bands was quantified using
Image Lab software (Bio-Rad, West Berkeley, CA, USA).
| Statistical analysis
The results are expressed as the mean ± SEM. A minimum of five independent samples was used in each group, and every analysis was repeated three times unless otherwise noted. Multigroup comparisons were performed using one-way analysis of variance followed by 3 | RESULTS
| Effect of berberine on 16HBE cell viability
To determine the optimal noncytotoxic berberine dose that significantly influences cell viability, the CCK-8 assay was carried out on 
| Effect of berberine on Nrf2 activation in 16HBE cells
Nrf2 is a unique transcription factor involved in cellular homeostasis;
Nrf2 phosphorylation leads to its translocation from the cytoplasm into the nucleus (Ma, 2013) . Therefore, the effect of berberine on by the CCK-8 assay ( Figure S1B ). ELISA results revealed that LPS stimulation upregulated proinflammatory factor (such as IL-6 and IL-8) levels in 16HBE cells, whereas nontoxic berberine doses (5 and 10 μM) substantially inhibited the LPS-induced upregulation of these cytokine levels (Figure 3a,b) . However, in the 2.5-μM group, the inhibitory effect of berberine was not significant. Similarly, changes in the gene expression levels of the inflammatory proteins mentioned above were demonstrated by the reverse transcription quantitative PCR assay (Figure 3c,d) . These results indicated that berberine (5 and 10 μM) reduced LPS-induced inflammatory cytokine production at both the protein and gene levels.
| Effect of berberine on ROS generation in LPSstimulated 16HBE cells
LPS binds to the cell via toll-like receptor 4, leading to the subsequent generation of ROS, which is associated with ALI and ARDS (Sanlioglu et al., 2001) . Therefore, we investigated whether LPS-induced airway epithelial cell injury was associated with enhanced ROS generation and examined the effect of berberine on this process. As shown in Figure 3e , after treatment of the 16HBE cells with 100-ng/ml LPS for 24 hr, the DCF fluorescence intensity was distinctly upregulated, which indicated higher intracellular ROS levels than those in the control group. These increases in ROS production were significantly decreased by treatment with berberine (5 and 10 μM). 3.6 | Effect of berberine on ER stress markers and unfolded protein response-related protein levels in LPS-stimulated 16HBE cells
Several reports have suggested that ER stress is involved in LPS-stimulated airway epithelial cells and further amplifies inflammatory reactions (H. J. Kim, Jeong, et al., 2013) . In the present study, LPS stimulation significantly increased the phosphorylation of PERK and eIF2α, as well as the expression of GRP78 and CHOP, in 16HBE cells.
Pretreatment with berberine (5 and 10 μM) reduced the LPS-induced changes in the above ER stress markers (Figure 5a ). In addition, the immunofluorescence intensities of GRP78 and CHOP were increased in the LPS-treated group compared with the control group, and this increase was substantially reduced by pretreatment with berberine ( Figure 5b ). These data suggested that berberine markedly inhibited ER stress in LPS-stimulated 16HBE cells.
| Effect of PERK and Nrf2 inhibition on berberine-mediated protection against LPS-induced ALI in vitro
Although both Nrf2 activation and the ER stress response are regulated by berberine, Nrf2 confers an anti-inflammatory action, whereas the PERK axis of the ER stress pathway promotes an inflammatory response. Based on these results, the roles of and possible (Figure 6a,b) . PERK or Nrf2 siRNA also significantly inhibited the expression levels of target proteins, which further reversed the regulation of these proteins by berberine (Figure 6c,g ).
Moreover, PERK siRNA treatment simultaneously decreased the expression intensity of p-eIF2α and CHOP (Figure 6d,f) , two key regulatory proteins downstream of PERK in ER stress signaling (Hetz, 2012) , FIGURE 4 Effect of berberine on Nrf2 activation in lipopolysaccharide (LPS)-stimulated 16HBE cells. The 16HBE cells were preincubated with berberine (5 and 10 μM) for 4 hr followed by LPS stimulation (100 ng/ml) for 24 hr. (a) Subcellular localization of the Cy3-labeled Nrf2 protein (as shown in magenta) in 16HBE cells was monitored under an FV1000 Olympus confocal microscope (n = 6). Scale bar: 50 μm. (b) Endogenous Nrf2 protein in the nuclear and cytoplasmic fractions of 16HBE cells was probed with a specific antibody via western blot analysis (n = 6). Lamin B1 and β-actin were probed as controls for the nuclear and cytoplasmic fractions, respectively. (c) Nrf2 DNA-binding activity in nuclear extracts from 16HBE cells was determined using a TransAM™ Nrf2 ELISA kit (n = 6). These results indicated that inhibition of ER stress enhanced the protective effect of berberine against LPS-induced ALI in vitro, while inhibiting Nrf2 produced the opposite effect.
| Effect of PERK and Nrf2 activation on berberine-mediated protection against LPS-induced ALI in vitro
In this part of the study, Tg and SF, which are effective agonists of ER stress and Nrf2, respectively, were used to further validate the above assumptions. First, the noncytotoxic doses of Tg and SF were analyzed by the CCK-8 assay. As shown in Figure 7a (Figure 7h-k) , whereas SF did not exhibit a similar inverse effect on ER stress (Figure 7d-g ). Based on the results presented above, the data revealed that inducing ER stress weakened the protective effect of berberine against LPS-induced ALI in vitro, whereas Nrf2 activation produced the opposite effect.
Thus, Nrf2 is downstream of ER stress (PERK protein), at least in the present context.
| Berberine treatment ameliorated LPS-induced lung injury in LPS-induced ALI mice
The LPS-induced mouse ALI model was established to study whether berberine exerts protective effects in vivo. As shown in Figure 8a , intratracheal treatment with LPS caused pathological changes by increasing the accumulation of inflammatory cells and alveolar hemorrhage in the alveolar space and the thickness of the alveolar septum, as shown by light microscopy, compared with control and berberine treatments. However, LPS-induced severe histopathological changes were noticeably attenuated by pretreatment with berberine or DXM, which were assessed in parallel with the lung injury score.
Additionally, the severity of edema was shown by W/D ratios of the lung and protein leakage into BALF. As illustrated in Figure 8b ,c, the protein concentration in BALF and W/D ratio of the lung were significantly higher in the LPS-stimulated group than in the normal and berberine-only treatment groups. In contrast, pretreatment with berberine and DXM remarkably decreased lung edema and protein leakage. Furthermore, the accumulation of Evans blue dye in lung tissue after tail vein injection, which is another indicator of vascular permeability, was evaluated. LPS injection exacerbated the aggregation of FIGURE 6 Effect of protein kinase-like ER kinase (PERK) and Nrf2 inhibition on berberine-mediated protection against lipopolysaccharide (LPS)-induced acute lung injury in vitro. After pretreatment with PERK small interference (siRNA) or Nrf2 siRNA for 48 hr, 16HBE cells were pretreated with berberine (5 μM) for 4 hr followed by LPS stimulation (100 ng/ml) for an additional 24 hr. The release of cytokines, including (a) IL-6 and (b) IL-8 (n = 6), was measured by enzyme-linked immunosorbent assay. The expression levels of endoplasmic reticulum (ER) stress markers, such as (c) phospho-PERK (p-PERK), (d) phospho-eIF2α (p-eIF2α), (e) glucose-regulated protein 78 (GRP78), and (f) C/EBP homologous protein (CHOP), in 16HBE cells were determined with specific antibodies via western blot analysis (n = 6). Moreover, the levels of Nrf2/heme oxygenase 1 (HO-1) pathway proteins, including (g) p-Nrf2, (h) N-Nrf2, (i) C-Nrf2, and (j) HO-1, in 16HBE cells were measured with specific antibodies via western blot analysis (n = 6). Lamin B1 and β-actin were probed as controls for the nuclear and cytoplasmic fractions, respectively. Values are expressed as the mean ± SEM. Statistical significance is indicated as demonstrated that intratracheal treatment with LPS evoked high levels of proinflammatory cytokines in BALF; however, berberine and DXM pretreatment effectively reduced these accumulations.
Taken together, the above results strongly suggested that berberine accelerated the resolution of inflammation in the mouse lung after LPS injury.
| Berberine treatment inhibited ER stress markers as well as activated the Nrf2 pathway in LPS-induced ALI mice
To further investigate the protective mechanism of berberine treatment on LPS-induced ALI, the expression levels of ER stress markers of ALI (Ware & Matthay, 2000) . As the interface between the external environment and the host, the respiratory epithelium maintains respiratory system homeostasis and is constantly exposed to invading particles and potential pathogens (Brazee et al., 2017) . Upon exposure to these noxious stimuli, alveolar and bronchial epithelial cells immoderately secrete inflammatory mediators, facilitating extensive tissue damage by recruiting innate and adaptive immune cells in the pathogenesis of ALI (Maus et al., 2002; Stegemann-Koniszewski et al., 2016) . LPS-induced ALI is a clinically relevant model that is widely used in laboratory research and replicates several key pathological processes of ALI, including cytokine release and the regulation of inflammatory signaling pathways (Hu et al., 2016) . The increased focus of investigations on therapeutic strategies against excessive inflammation in this model is encouraging (Hu et al., 2016; Qi et al., 2016; Zou et al., 2017) . However, despite several important clinical and laboratory advances in ALI treatment during the last few decades, the therapeutic effect of these treatments is still undetermined; therefore, discovering new drugs and new therapeutic targets remains an urgent priority.
Berberine, a bioactive alkaloid isolated from several herbal substances, has historically been used in traditional Chinese medicine (Kong et al., 2004) . In the past few years, berberine has gained interest due to its unique pharmacological properties for the treatment of several conditions, including some inflammatory diseases. For example, berberine pretreatment reduces LPS-induced inducible NO synthase protein expression and the cytoplasmic translocation of human antigen R in liver tissues and increases the survival rate of mice with LPS-induced endotoxemia (Shin et al., 2016) . Zhang et al. (2008) also demonstrated that berberine attenuates LPS-induced lung injury by inhibiting tumor necrosis factor α (TNF-α) production and attenuates the expression and activation of cytosolic phospholipase A2 in an alpha2 adrenoceptor-independent manner. Moreover, exposure to different stimuli is known to result in the generation of ROS in airway epithelial cells (Levine, 1995) . Excessive ROS could boost inflammatory signaling in neutrophils and promote a significant increase in their chemotactic activity via a paracrine mechanism, which would further induce apoptosis in the upper respiratory compartment (Cheng et al., 2016; Neff et al., 2006) . Therefore, inhibition of ROS generation should be effective against LPS-induced ALI neutrophil accumulation in the lung, which boost inflammatory cytokine release and cell aggregation to increase the severity of ALI, are effectively reversed by berberine treatment. Importantly, after LPS insult, excessive secretion of inflammatory mediators, such as TNF-α, IL-6, IL-1β, and KC, which are strongly related to the development of acute and chronic inflammation diseases, is observed in the mouse ALI model (Matute-Bello et al., 2011) . Berberine, however, significantly reduced IL-6 and KC secretion in LPS-induced ALI mice. These results indicate the protective effect of berberine against ALI in vitro and in vivo; however, the underlying mechanism requires further study.
ER stress is a well-known, potent evolutionarily conserved mechanism for recovering ER homeostasis that is activated in cells in response to perturbations, such as inflammatory responses (Todd et al., 2008) . Studies have shown that the PERK-eIF2α-CHOP pathway, one of the three classical ER stress pathways, is associated with the pathogenesis of some pulmonary disorders, particularly LPSinduced ALI and asthma (Kaphalia & Calhoun, 2013) . Zeng et al. (2017) showed that ER stress is a key promoter of LPS-induced inflammation and that the protective effect of 4-phenylbutyrate is related to ER stress inhibition and autophagy in LPS-induced ALI models, as evidenced by decreased p-PERK, GRP78, and CHOP expression levels.
Moreover, a study by Kim, GRP78 and CHOP protein levels were significantly higher in peripheral blood mononuclear cells obtained from patients with severe lung inflammation than in those from healthy patients; GRP78 and CHOP protein levels were also increased in LPS-treated HBE cells (H. J. Kim, Jeong, et al., 2013) . Similar results were found in our study. After LPS stimulation, p-PERK, p-eIF2α, and CHOP expression was markedly upregulated in vitro and in vivo, and GRP78 expression was greater than that in the control group.
These changes in ER stress markers demonstrated that LPS accelerated GRP78 dissociation from other ER stress sensors (e.g., PERK), further releasing stress sensors to permit downstream signaling (eIF2α and CHOP). Berberine pretreatment significantly reduced the increase in these protein levels, which alleviated the degree of LPS-induced inflammation in vitro and in vivo. In addition, PERK-specific siRNA and an ER stress agonist (Tg) were used to investigate the role of the PERK-eIF2α-CHOP pathway in the protective effect of berberine against LPS-induced ALI. Small interference RNA treatment not only reduced PERK phosphorylation but also strengthened the inhibitory effect of berberine on ER stress. Additionally, the inflammatory response was further reduced, as indicated by the decrease in IL-6
and IL-8 concentrations. However, cotreatment with Tg and berberine induced the opposite effects. The above results imply that berberine plays an anti-inflammatory role via amelioration of ER stress.
Nrf2 has emerged as a pivotal regulator in ALI and induces several intracellular detoxifying enzymes and antioxidant proteins to maintain cellular homeostasis (Hybertson, Gao, Bose, & McCord, 2011) .
Recently, studies have demonstrated that Nrf2 also exerts protective effects in LPS-induced models of lung damage in vitro and in vivo. Lv et al. (2017) showed that Nrf2-deficient mice are more susceptible to lung damage and that Nrf2 activation suppresses LPS-induced nucleotide-binding domain-like receptor protein 3 inflammasomes and the nuclear factor-κB (NF-κB) signaling pathway. The results from another research group demonstrated that activating the Nrf2 pathway by Nrf2 Ser40 phosphorylation and nuclear translocation leads to recovery of E-cadherin expression, reducing airway permeability and protecting mice from LPS-induced inflammation in airway epithelial cells (Cheng et al., 2016 ). In our current investigation, berberine administration alone dose dependently increased Nrf2 expression and nuclear accumulation in LPS-induced 16HBE cells or ALI mice. Nrf2 phosphorylation at Ser40 is a mechanism involved in nuclear translocation (Bryan, Olayanju, Goldring, & Park, 2013) . Therefore, it was necessary to evaluate the berberine-induced change in p-Nrf2. Consistent with nuclear Nrf2 accumulation, Nrf2 pSer40 was promoted after berberine treatment, which partially uncovered the mechanism underlying berberine-mediated Nrf2 activation. Based on the above results, berberine may play a protective role in the lungs against LPS-induced disruption.
Following LPS stimulation, Nrf2 was partially transferred from the cytoplasm into the nucleus, which is a stress response following an insult. In LPS-induced 16HBE cells and ALI mice, berberine administration markedly promoted this translocation. Moreover, as a basic leucine zipper transcription factor, Nrf2 has been shown to regulate gene expression by binding with AREs to alleviate environmental or endogenous stress (Ma, 2013; Zimmermann et al., 2015) . HO-1 is an important Nrf2-targeted cytoprotective enzyme (Cho et al., 2006) .
Berberine pretreatment further promoted not only ARE activity but also HO-1 expression in a dose-dependent manner in vitro. After cells were treated with SF, an Nrf2 activator, the berberine-mediated prevention of LPS-induced damage was further amplified, whereas in a parallel group, Nrf2 inhibition with the special siRNA conversely hindered this effect. Therefore, using the Nrf2-ARE binding assay as a transcriptional indicator of Nrf2, we provided direct evidence that berberine activates the Nrf2 pathway in LPS-treated airway epithelial cells, including increased Nrf2 expression, Ser40 phosphorylation and nuclear translocation, and downstream HO-1 protein activation.
The dissociation of Nrf2 from KEAP1 by PERK is another mechanism involved in nucleocytoplasmic shuttling (Bryan et al., 2013) .
Under homeostatic conditions, Nrf2 is sequestered in a cytoplasmic complex through its interaction with the actin-binding protein KEAP1
and is targeted for proteasomal degradation (Itoh et al., 1999) . Under some stress conditions, activated PERK phosphorylates its substrate, eIF2α, to attenuate protein synthesis and restore ER homeostasis; in other conditions, PERK modifies Nrf2 conformation to protect cells from the insult (Harding, Zhang, Bertolotti, Zeng, & Ron, 2000; Huang, Nguyen, & Pickett, 2000) . Cunha et al. (2016) showed that PERK phosphorylation consequently promotes Nrf2 activation, thereby equipping β cells with an effective antioxidant stress defense mechanism against palmitate exposure. Research from Li's group also indicated that baicalin pretreatment has a protective effect against H 2 O 2 -induced cytotoxicity in HK-2 cells, in which ER stress and downstream Nrf2 signaling are involved (Lin et al., 2014) . In our study, berberine treatment significantly resulted in the activation of Nrf2 and the inhibition of ER stress in 16HBE cells and mice. Therefore, to further examine the relationship between ER stress (especially PERK) and Nrf2 activation by berberine, cells were pretreated with a specific siRNA or agonist (Tg for PERK and SF for Nrf2). Similar to previous studies, induction of ER stress and Nrf2 inhibition abrogated the protective effects of berberine against bacterial endotoxins, whereas suppressing ER stress and Nrf2 activation further improved those protective effects. Meanwhile, after berberine and LPS treatment, PERK depletion by siRNA partly reduced Nrf2 phosphorylation and the translocation of Nrf2 from the cytoplasm into the nucleus. However, Nrf2 siRNA had little effect on PERK activity under the same conditions. In contrast, Tg-induced ER stress led to analogous Nrf2 activation, whereas SF did not exhibit an inverse effect on ER stress.
These changes indicated an up-and-down relationship between ER stress and Nrf2. Additionally, in the present study, treatment with Tg alone induced significant ER stress, further inducing Nrf2 activation, which is consistent with previous studies (Cullinan et al., 2003) . Under this condition, 16HBE cells suffered from the inflammatory state, as evidenced by the rapid increase in IL-6 and IL-8 levels. However, in the unstressed state, such as treatment with PERK siRNA only, the inactivation of Nrf2 was not notable. Importantly, LPS evoked marked inflammation with ER stress, similar to the influence of Tg. Additionally, increased ER stress can be regarded as an important damaging factor. In this situation, LPS-induced activation of Nrf2 appears to be a defense mechanism regulated by PERK. Once PERK was inhibited by berberine, the injury (or inflammatory response) was reduced, but the above-mentioned defense mechanism was also reduced, and the cells tended to appear to be in a normal state.
In summary, our findings demonstrated that berberine effectively protected against ALI from LPS-induced inflammatory damage, which was partly dependent on the inhibition of ER stress via activation of the Nrf2 pathway. As illustrated in Figure 11 , in some instances, LPS stimulates PERK phosphorylation to evoke ER stress and also activates Nrf2 which partly appears to be a defense factor. Prolonged PERK pathway activation during bacterial infection essentially contributes to the development of ALI. Berberine inhibits ER stress to weaken the inflammatory response. Berberine also markedly enhances the body's protective response, namely, via Nrf2 activation, including FIGURE 11 Scheme summarizing the protective effects of berberine against LPS-induced acute lung injury (ALI) via the PERK-mediated Nrf2/ HO-1 signaling axis. Berberine treatment effectively protected against LPS-induced ALI by inhibiting ER stress via the Nrf2-mediated antiinflammatory pathway, with a greater contribution from the latter. ARE: antioxidant response element; CHOP: C/EBP homologous protein; eIF2α: α-subunit of eukaryotic translation initiation factor 2; ERS: endoplasmic reticulum stress; GRP78: glucose-regulated protein 78; HO-1: heme oxygenase 1; IL: interleukin; LPS: lipopolysaccharide; Nrf2: nuclear factor-erythroid 2-related factor 2; PERK: protein kinase-like ER kinase; ROS: reactive oxygen species; p: phosphorylation [Colour figure can be viewed at wileyonlinelibrary.com] Ser40 phosphorylation and nuclear translocation. By this method, berberine modulates the expression of ARE-containing genes and protects lung tissue from endotoxin damage. Although Nrf2 may be a novel PERK substrate (Cullinan et al., 2003) , p-PERK inhibition by berberine does not affect the anti-inflammatory role of Nrf2 because berberine has a stronger activating effect, which suggests that berberine may effectively prevent infection-related diseases, especially ALI.
